NovAccess Global Inc. (XSNX)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Oct 12, 2026
NovAccess Global Market Cap
NovAccess Global has a market cap or net worth of $6.17 thousand as of October 20, 2026. It is the 51,961st most valuable company in the world and the 7,976th biggest in the United States.
Market Cap
6.17K
Enterprise Value
7.13M
Revenue
n/a
Global Rank
Country Rank
#7,976 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since September 18, 1998, NovAccess Global's market cap has decreased from 26.88M to 6.17K, a decrease of -99.98%. That is a compound annual growth rate of -25.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 12.33K | 100.00% |
| Dec 31, 2025 | 6.17K | -99.00% |
| Dec 31, 2024 | 616.52K | 28.36% |
| Dec 29, 2023 | 480.31K | -91.60% |
| Dec 30, 2022 | 5.72M | 10.69% |
| Dec 31, 2021 | 5.17M | 66.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| 0913693 B.C. | 7.36K |
| Statera Biopharma | 7.26K |
| IO Biotech | 7.20K |
| Therapeutic Solutions International | 7.05K |
| Entia Biosciences | 6.81K |
| Theralink Technologies | 6.15K |
| Scorpius Holdings | 6.11K |
| Hard to Treat Diseases | 5.82K |